Victoria 2489150090 is a B2B platform for licensed clinicians and qualified practitioners. Access is limited to professionals who prescribe and manage care for their own patients.
By proceeding you affirm the statements above are true. Victoria 2489150090 is not a patient marketplace or provider network — products are available only to enrolled clinicians for care of their own patient panels.

FOXO4-DRI (or Proxofim) is a research peptide designed to eliminate senescent cells—cells that stop dividing but cause inflammation (SASP) and accelerate aging—by inhibiting the interaction between FOXO4 and p53.
For laboratory and research use only. Not for human or veterinary use.